Tae Min Kim

Seoul National University Hospital

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Cancer Biology Cancer Biology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (21)

Heejoon Jang

Assistant Professor

Seoul Metropolitan Government Seoul National University Boramae Medical Center

SOUTH KOREA

View details

Andrew Armstrong

Professor

Duke Cancer Institute

UNITED STATES

View details

Eun Ju Cho

SOUTH KOREA

View details

Gyeong-Won Lee

Gyeongsang National University

SOUTH KOREA

View details

Se‐Hoon Lee

SOUTH KOREA

View details

Soon-Tae Lee

Professor

Seoul National University Hospital

SOUTH KOREA

View details

Danny Nguyen

Assistant Clinical Professor

City of Hope

UNITED STATES

View details

Adam Olszewski

Associate Professor of Medicine

Rhode Island Hospital

UNITED STATES

View details

Seung Hong Choi

Professor

Seoul National University College of Medicine

SOUTH KOREA

View details

Chul-Kee Park

Professor

Seoul National University College of Medicine

SOUTH KOREA

View details

Jeong-Hoon Lee

Professor

Seoul National University Hospital

SOUTH KOREA

View details

KYONG HWA PARK

Associate Professor

Seoul National University Hospital

SOUTH KOREA

View details

Ulrich Jaeger

Medical University of Vienna

AUSTRIA

View details

Yong Jin An

Seoul National University College of Pharmacy

SOUTH KOREA

View details

Amitkumar Mehta

Assistant professor

The University of Alabama

UNITED STATES

View details

Tycel Phillips

University of Michigan Medical School

UNITED STATES

View details

Dong-Wan Kim

Associate Professor

Seoul National University Hospital

SOUTH KOREA

View details

Ji Ye Lee

Seoul National University Hospital

SOUTH KOREA

View details

Silvana Novelli

SPAIN

View details

Michał Taszner

Medical University of Gdansk

POLAND

View details

Sung Hye Park

Professor

Seoul National University College of Medicine

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tae Min Kim

Research Interests

Explore related searches

Contact this professor

Articles (20)

Transcriptomic Heterogeneity of EGFR-Mutant Non–Small Cell Lung Cancer Evolution Toward Small-Cell Lung Cancer

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Rearranged or Translocated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial

CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial

Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma

CHRONOS-4: phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma

A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)

Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma

Histological transformation to small-cell carcinoma

Matching-Adjusted Indirect Comparison of Amivantamab vs Mobocertinib in Platinum-Pretreated EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer

Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study

Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer

The antitumor activity of a novel GCN2 inhibitor in head and neck squamous cell carcinoma cell lines

A phase Ia/Ib study of novel anti‐ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancer

Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study

A multicenter, phase II trial of GC1118, a novel anti‐EGFR antibody, for recurrent glioblastoma patients with EGFR amplification

Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinoma

Ex vivo NMR metabolomics approach using cerebrospinal fluid for the diagnosis of primary CNS lymphoma: Correlation with MR imaging characteristics

Cluster Analysis of DSC MRI, Dynamic Contrast-Enhanced MRI, and DWI Parameters Associated with Prognosis in Patients with Glioblastoma after Removal of the Contrast-Enhancing Component: A Preliminary Study

Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort

Collaborators (21)

Heejoon Jang

Andrew Armstrong

Eun Ju Cho

Gyeong-Won Lee

Se‐Hoon Lee

Soon-Tae Lee

Danny Nguyen

Adam Olszewski

Seung Hong Choi

Chul-Kee Park

Jeong-Hoon Lee

KYONG HWA PARK

Ulrich Jaeger

Yong Jin An

Amitkumar Mehta

Tycel Phillips

Dong-Wan Kim

Ji Ye Lee

Silvana Novelli

Michał Taszner

Sung Hye Park

Make your next move.